Rupam Bhattacharjee

  • Citations Per Year
Learn More
The recent advances in microfluidic technology have resulted in the emergence of commercially successful lab-on-chip systems that manifested as applicable devices in the wide range of areas e.g. high-throughput DNA sequencing, immunoassays and clinical chemistry, environmental toxicity monitoring and point of- care diagnosis of diseases. The current(More)
Digital micro fluidic biochips (DMFB) represent a new generation lab-on-a-chip architecture based upon micromanipulation of droplets via a programmed external electric field by an individually addressable 2D electrode array. DMFBs are classified as: Direct addressing and Cross-referencing biochips. Cross-referencing biochip technology scales down the number(More)
Digital microfluidic systems in recent years have been developed as an alternative platform for execution of multiple conventional laboratory methods simultaneously on a single planar 2D array of electrodes targeted for biochemical analysis and biomedical applications. Due to its discrete nature droplets can be manipulated through multiple reconfigurable(More)
  • 1